EU likely to decline new vaccine deals with Astrazeneca and J&J

The EU is negotiating with Pfizer/Biontech and Moderna for new vaccine contracts, states French economy minister, but it's unlikely the union it will reach out to Astrazeneca or Johnson & Johnson.

Photo: Dado Ruvic/REUTERS / X02714

It improbable that the EU will renew its vaccine contract with British-Swedish Astrazeneca, and no negotiations have been entered into with US giant Johnson & Johnson either, says Secretary of State for Economy and Finance Agnes Pannier-Runacher, according to news agency AFP.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs